Latest News and Press Releases
Want to stay updated on the latest news?
-
Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at EACCI 2025
-
Upstream Bio to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
-
Upstream Bio Appoints Stacy Price as Chief Technology Officer
-
Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
-
– Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data expected in the second half of 2025 – – Completed upsized IPO...
-
Upstream Bio to Present at Upcoming March Investor Conferences
-
Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Upstream appoints Allison Ambrose as General Counsel
-
Upstream Bio (Nasdaq:UPB) to be added to Russell 2000® index effective at the open of the U.S. equities market on Monday, December 23.
-
Upstream Bio CEO to participate in fireside chat at Piper Sandler